A multicenter, randomized phase III study of second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients who progressed to a first-line treatment containing bv: results from the bebyp trial by the Gruppo Oncologico Nord Ovest (GONO) / SALVATORE L; MASI G; LOUPAKIS F; CREMOLINI C; SCHIRRIPA M; FORNARO L; ANTONIOTTI C; VIVALDI C; GRANETTO C; FEA E; ANTONUZZO L; GIOMMONI E; BONI C; BANZI M; CHIARA S; SONAGLIO C; ALLEGRINI G; MARCUCCI L; VALSUANI C; GRECO F; SAFINA V; BONI L; FALCONE A. - In: TUMORI. - ISSN 0300-8916. - (2012), p. S23. ((Intervento presentato al convegno XIV National Congress of Medical Oncology tenutosi a Roma nel 27 -29 Ottobre.
Titolo: | A multicenter, randomized phase III study of second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients who progressed to a first-line treatment containing bv: results from the bebyp trial by the Gruppo Oncologico Nord Ovest (GONO). |
Autori interni: | |
Anno del prodotto: | 2012 |
Rivista: | |
Handle: | http://hdl.handle.net/11568/245973 |
Appare nelle tipologie: | 4.1 Contributo in Atti di convegno |